| 摘要 |
2119019 9305809 PCTABS00021 Treatment or prevention of myointimal proliferation in atherosclerosis, restenosis induced by angioplasty or vascular reconstructive surgery, glomerulonephritis, glomerulosclerosis or other diseases involving vascular cell proliferation, with a natriuretic peptide or a neutral endopeptidase inhibitor such as N-¢N-¢(L)-¢1-¢(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy!carbonyl!-2-phenylethyl_ !-L-phenylalanyl!-.beta.-alanine and N-¢2-mercaptomethyl-3-(2-methylphenyl)propionyl!-methionine, or with a neutral endopeptidase inhibitor in combination with a natriuretic peptide or an angiotensin converting enzyme inhibitor are disclosed.
|
